Infection Prevention and Control Lapse Disclosures | Hastings Prince Edward Public Health

Infection Prevention and Control Lapse Disclosures

The Ministry of Health and Long-Term Care has directed all public health units to publicly disclose more detailed information on non-routine infection prevention and control (IPAC) lapse investigations where they are identified.  An IPAC lapse is a departure from infection prevention and control standards.  The result could be infectious disease transmission to patients or staff through exposure to blood or body fluids.  An example would be medical equipment that is improperly cleaned and can spread infections from one patient to another.

This page contains reports on premises where an IPAC lapse was identified through the assessment of a complaint or referral, or through communicable disease surveillance.  It does not include reports of premises which were investigated following a complaint or referral where no infection prevention and control lapse was ultimately identified.

These reports are not exhaustive, and do not guarantee that those premises listed are free of infection prevention and control lapses.  Identification of lapses is based on assessment and investigation of a premise at a point in time.  These assessments and investigations are triggered when potential infection prevention and control lapses are brought to the attention of the local Medical Officer of Health.

For more information regarding these lapses please contact Stephanie McFaul at 613-966-5500 ext. 266.

IPAC Investigation Reports

You Make Me Smile Dental Centre - Dr. Younes (2 Sites - Trenton & Belleville) (December 2018)

Bayview Mall Medical Clinic - Dr. Vukojevic (January 2017)

Please note: IPAC investigation reports are posted on this page as per the Ontario Public Health Standards, Infection Prevention and Control Complaints Protocol  (the protocol). If the outcome of an investigation is such that a risk is identified that requires action on the part of patients, the protocol also ensures processes are in place to clearly notify patients of such risks and recommended action either directly or through a public news release.